A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants

NCT02427958 PHASE4 COMPLETED Results posted

The purpose of this study is to assess long-term safety and efficacy of leuprorelin in the treatment of Central Precocious Puberty (CPP).

Details

Lead sponsor	Takeda
Phase	PHASE4
Status	COMPLETED
Enrolment	307
Start date	Fri Aug 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Nov 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Central Precocious Puberty

Interventions

• Leuprorelin

Countries

China